These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 19374202)

  • 1. [Exogenous allergic alveolitis].
    Lo Cascio C; Saur M; Steurer-Stey C
    Praxis (Bern 1994); 2009 Jan; 98(1):5-12; quiz 13-4. PubMed ID: 19374202
    [No Abstract]   [Full Text] [Related]  

  • 2. [Extrinsic allergic alveolitis].
    Pabst S; Weisser B; Vetter H; Grohé Ch
    Praxis (Bern 1994); 2004 Apr; 93(16):643-8. PubMed ID: 15192845
    [No Abstract]   [Full Text] [Related]  

  • 3. Additive effects of inhaled formoterol and budesonide in reducing asthma exacerbations.
    Pauwels R
    Allergy; 1998; 53(42 Suppl):20-3. PubMed ID: 9615842
    [No Abstract]   [Full Text] [Related]  

  • 4. Budesonide and formoterol combination for the treatment of chronic obstructive pulmonary disease.
    Centanni S; Di Marco F
    Expert Opin Pharmacother; 2005 Nov; 6(14):2525-34. PubMed ID: 16259583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lost in the labyrinth of end points.
    Lipworth BJ
    Chest; 2001 Jul; 120(1):323-4. PubMed ID: 11451868
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined budesonide/formoterol turbuhaler treatment of asthma.
    Remington TL; Heaberlin AM; DiGiovine B
    Ann Pharmacother; 2002 Dec; 36(12):1918-28. PubMed ID: 12452756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Budesonide/formoterol in the treatment of asthma.
    Hodgson D; Mortimer K; Harrison T
    Expert Rev Respir Med; 2010 Oct; 4(5):557-66. PubMed ID: 20923335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Availability of the combination of formoterol and budesonide in the United States of America.
    Blango CM; O'Brien CD
    Allergy Asthma Proc; 2008; 29(4):426. PubMed ID: 18702893
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of budesonide and formoterol on NF-kappaB, adhesion molecules, and cytokines in asthma.
    Wilson SJ; Wallin A; Della-Cioppa G; Sandström T; Holgate ST
    Am J Respir Crit Care Med; 2001 Sep; 164(6):1047-52. PubMed ID: 11587995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy and safety of budesonide-formoterol in non-cystic fibrosis bronchiectasis.
    Martínez-García MÁ; Soler-Cataluña JJ; Catalán-Serra P; Román-Sánchez P; Tordera MP
    Chest; 2012 Feb; 141(2):461-468. PubMed ID: 21778259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidetector-row computed tomography assessment of adding budesonide/formoterol to tiotropium in patients with chronic obstructive pulmonary disease.
    Yasui H; Inui N; Furuhashi K; Nakamura Y; Uto T; Sato J; Yasuda K; Takehara Y; Suda T; Chida K
    Pulm Pharmacol Ther; 2013 Jun; 26(3):336-41. PubMed ID: 23340058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Budesonide plus formoterol for reliever therapy in asthma.
    Pedersen S
    Lancet; 2006 Aug; 368(9537):707-8. PubMed ID: 16935666
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of inhaled budesonide and formoterol on bronchial remodeling and HRCT features in young asthmatics.
    Capraz F; Kunter E; Cermik H; Ilvan A; Pocan S
    Lung; 2007; 185(2):89-96. PubMed ID: 17393237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.
    Pauwels RA; Löfdahl CG; Postma DS; Tattersfield AE; O'Byrne P; Barnes PJ; Ullman A
    N Engl J Med; 1997 Nov; 337(20):1405-11. PubMed ID: 9358137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Budesonide and formoterol in a single inhaler improves asthma control compared with increasing the dose of corticosteroid in adults with mild-to-moderate asthma.
    Lalloo UG; Malolepszy J; Kozma D; Krofta K; Ankerst J; Johansen B; Thomson NC
    Chest; 2003 May; 123(5):1480-7. PubMed ID: 12740264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single inhaler budesonide/formoterol in exacerbations of chronic obstructive pulmonary disease.
    Cazzola M
    Pulm Pharmacol Ther; 2006; 19(2):79-89. PubMed ID: 15964228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjustable maintenance dosing with budesonide/formoterol reduces asthma exacerbations compared with traditional fixed dosing: a five-month multicentre Canadian study.
    FitzGerald JM; Sears MR; Boulet LP; Becker AB; McIvor AR; Ernst P; Smiljanic-Georgijev NM; Lee JS;
    Can Respir J; 2003; 10(8):427-34. PubMed ID: 14679407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudobronchiectasis after pertussis and mycoplasma infection.
    Aung AK; Thompson PJ; Teh BM; McGrath C
    Am J Respir Crit Care Med; 2012 Aug; 186(3):292-4. PubMed ID: 22855546
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost effectiveness of budesonide/formoterol in a single inhaler for COPD compared with each monocomponent used alone.
    Löfdahl CG; Ericsson A; Svensson K; Andreasson E
    Pharmacoeconomics; 2005; 23(4):365-75. PubMed ID: 15853436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Budesonide/formoterol maintenance and reliever therapy in moderate-to-severe asthma: effects on eosinophilic airway inflammation.
    Takeyama K; Kondo M; Tagaya E; Kirishi S; Ishii M; Ochiai K; Isono K; Tamaoki J
    Allergy Asthma Proc; 2014; 35(2):141-7. PubMed ID: 24717791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.